Career history of Hana Chen-Walden
Former positions of Hana Chen-Walden
| Companies | Position | Start | End |
|---|---|---|---|
| BIOXYTRAN, INC. | Director/Board Member | - | 2024-04-18 |
| Independent Dir/Board Member | - | 2024-04-18 | |
| Covalent Group, Inc. | General Counsel | 2002-12-31 | 2002-12-31 |
| NANOMIX CORPORATION | Chief Tech/Sci/R&D Officer | - | - |
Training of Hana Chen-Walden
| Tel-Aviv University | Doctorate Degree |
Statistics
International
| United States | 4 |
| Israel | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| General Counsel | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BIOXYTRAN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
| Covalent Group, Inc. | Commercial Services |
- Stock Market
- Insiders
- Hana Chen-Walden
- Experience
